Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Minister says there were ‘many things’ Government did not get right in pandemic

While acknowledging there are ‘lessons to learn’ from the Covid-19 crisis, Lord Markham also pointed to successes.

The Independent UK

Date-rape drugs could be detected in drinks using smartphones

Researchers spotted the presence of Liquid Ecstasy in drinks using readily available chemicals and a free app.

Evening Standard

The #1 Pharma Stock to Buy in January 2023

While the stock market and the economy have been subdued by progressive interest-rate increases, AbbVie Inc. (ABBV) has not only reported a robust third quarter but also demonstrated its confidence in its long-term prospects by raising its quarterly dividend. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Charity launched by East Midlands entrepreneur helping improve the lives of 50,000 Ugandan girls and women

The Randal Charitable Foundation was launched by entrepreneur Dr Nik Kotecha OBE DL and Mrs Moni Kotecha

Birmingham Post

Celadon becomes first UK company to clear regulatory hurdle to manufacture medical cannabis

The UK cannabis market could be worth as much as £1bn by 2026

Evening Standard

Florida agency warns pharmacists not to dispense abortion pills

FORT LAUDERDALE, Fla. — With pharmacies in some states preparing to dispense abortion pills, Florida’s Agency for Healthcare Administration sent a letter Thursday to all state health care providers warning them that to do so in Florida is illegal.

Tribune News Service

Fentanyl panic mirrors crack epidemic

Instead of learning from the past, fear and panic are driving policy that doubles down on failed tactics

Salon

Read news from The Economist, FT, and more,
with one subscription

Brexit worsened UK medicine shortages and NHS budget pressures, expert says

THE turning point was the Brexit referendum. Before voting to leave the EU in June 2016, medicine shortages were not something the UK often had to…

The National (Scotland)

Old Irish cures for common illnesses that you shouldn't try at home

With cures like these, we're glad for modern medicine

Dublin Live

Fujifilm Diosynth Biotechnology reports big profit increase amid work to expand North East base

The Japanese manufacturer made investment into its UK operation as part of a £600m global programme

Birmingham Post

Fentanyl cited by NYC health officials for 27% jump in citywide drug overdose fatalities during 2021

NEW YORK — New York City’s drug overdose deaths soared by 27% in 2021, with four in every five linked to fentanyl as the city’s Black community and the Bronx reported a disproportionately highest number of fatalities, city officials said.

Tribune News Service

Snake tries to shed its skin

Several generations of Thais are familiar with the "arrow-stuck snake" logo of the cooling talcum powder brand, but The British Dispensary Co wants to transform its product lines after more than a century in business.

Bangkok Post

1 Drug Store Stock to Buy in 2023 and 1 to Sell

The demand for drugstore products is significantly rising owing to the growing prevalence of chronic diseases, an aging population, and favorable government policies. Hence, investing in fundamentally sound drugstore stock CVS Health (CVS) could be wise. However, it might be wise to avoid Rite Aid (RAD) due to its deteriorating…

StockNews.com

2 Biotech Stocks Under $100 to Buy Now

The biotech industry flourished amid the pandemic, and lucrative federal investments are expected to drive further growth in the sector. Moreover, amid evolving variants of Coronavirus, the biotech industry is expected to remain in the limelight. Given the sound prospects of the industry, quality biotech stocks Gilead Sciences (GILD) and…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Bristol Post

Tributes to Bristol Drugs Project pioneer Maggie Telfer, who has died at 63

"Maggie’s leadership, compassion and indomitable spirit inspired all around her"

StockNews.com

1 Large-Cap Stock You Should Purchase This Week

Pharmaceutical company Novartis (NVS) maintained its growth momentum in the third quarter of fiscal 2022, and the company’s growth prospects look promising, supported by its clear focus on five core therapeutic areas, having multiple significant in-market and pipeline assets. Given NVS’ reliable dividend payments and high profitability, this large-cap stock…

Daily Record

Safe consumption rooms progress has been too slow, says Scottish Labour

There has been little movement towards the roll-out of safe consumption rooms in the 14 months since the Lord Advocate confirmed there was a legal route to pursuing them.

WEKU

Many workers barely recall signing noncompetes, until they try to change jobs

Employers say that noncompete agreements are needed to protect trade secrets and investments. The FTC says they deprive workers of their economic liberties and has proposed a rule to ban them.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

The US government spent $30bn developing the Covid vaccine. So how can Moderna plan to charge $110 a jab?

Vaccines were built in part on government research and funding, but treatment won’t be free to Americans much longer

StockNews.com

Bristol-Myers Squibb (BMY) is a Top Value Stock for 2023

The bear market has been downright brutal for growth stocks. Thus making it clear that now is the time for value. That is why you need to discover the attractiveness of Bristol-Myers Squibb (BMY) shares. Read on below for the full story.

The National (Scotland)

£68m plan to tackle Scotland's drug deaths emergency unveiled

THE Scottish Government has unveiled a £68 million package of measures aimed at tackling the country’s drug deaths crisis.

Dublin Live

Dublin pharmacist warns against stockpiling amid surge in demand for Calpol

Tomas Conefrey, who runs Conefrey's CarePlus Pharmacy on Pearse Street, says that panic purchases of Calpol and Nurofen are occurring in store

WEKU

The FDA no longer requires all drugs to be tested on animals before human trials

In a victory for animal rights advocates, drugmakers can take their products to human clinical trials using alternative testing methods that don't involve animals.

Daily Mirror

Local chemists suffering £67,000 annual shortfall, say pharmacists' leaders

The Company Chemists’ Association blasted the "truly broken" funding system and warned the Government that pharmacists needed extra cash to help ease the desperate NHS crisis

StockNews.com

The No. 1 Stock to Keep an Eye on in 2023

Bristol-Myers Squibb Company (BMY) launched three first-in-class therapies across different disease areas last year. Moreover, the company is waiting for the FDA’s approval of repotrectinib this year. These new products are expected to drive the company’s long-term growth. So, it could be wise to keep an eye on BMY this…

1 … 64 65 66 67

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

Federal Trade Commission

184 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.